Table 1.
Control | mTBI | p-value Control vs mTBI a | Low Symptom mTBI | High Symptom mTBI | p-value High vs Low Symptom b | |
---|---|---|---|---|---|---|
N | 30 | 41 | 15 | 26 | ||
Age (yrs) | 38.67 ± 18.11 | 43.68 ± 16.98 | 0.236 | 41.80 ± 20.38 | 44.77 ± 14.98 | 0.627 |
Education (yrs) | 15.10 ± 2.02 | 14.32 ± 2.72 | 0.192 | 15.27 ± 2.94 | 13.77 ± 2.49 | 0.090 |
GCS | NA | 14.73 ± 0.59 | NA | 14.87 ± 0.35 | 14.65 ± 0.69 | 0.199 |
Gender (M) | 16 | 30 | 0.086 | 13 | 17 | 0.146 |
Positive CT | NA | 9 (22.0%) | NA | 4 (26.7%) | 5 (19.2%) | 0.591 |
Days Since Injury Initial | NA | 7.66 ± 2.36 | NA | 6.67 ± 2.58 | 8.23 ± 2.07 | 0.039** |
Days Since Injury 1 month | NA | 36.00 ± 8.18 | NA | 39.20 ± 10.96 | 34.15 ± 5.49 | 0.113 |
MMSE Initial | 29.80 ± 0.61 | 29.28 ± 0.82 | 0.003** | 29.43 ± 0.76 | 29.19 ± 0.85 | 0.389 |
MMSE 1 month | 29.40 ± 0.93 | 29.34 ± 1.02 | 0.805 | 29.60 ± 0.63 | 29.19 ± 1.17 | 0.155 |
MACE Initial | 27.40 ±1.85 | 25.93 ± 4.22 | 0.053 | 26.67 ± 1.50 | 25.48 ± 5.21 | 0.294 |
MACE 1 month | 28.07 ± 1.58 | 27.02 ± 3.51 | 0.099 | 27.13 ± 2.59 | 26.96 ± 4.00 | 0.883 |
DRS 1 month | NA | 0.41 ± 0.91 | NA | 0.03 ± 0.13 | 0.63 ± 1.09 | 0.010** |
GOSE 1 month | NA | 6.71 ± 1.72 | NA | 7.40 ± 1.12 | 6.31 ± 1.89 | 0.026** |
Based on t-tests between control and mTBI groups.
Based on t-tests between high symptom mTBI and low symptom mTBI groups.